S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
3 lithium stocks to ride a multi-year cycle
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Goldman upgraded Nvidia stock, one metric says it could go higher
Autozone stock price is still in the rally zone
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
New highs are coming for Lowe’s stock despite mixed results
Closing prices for crude oil, gold and other commodities
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Consumer confidence slips in February as anxiety over potential recession surprisingly reappears
Beyond Meat's shares soar on better-than-expected Q4 revenue despite weak US sales
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
3 lithium stocks to ride a multi-year cycle
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Goldman upgraded Nvidia stock, one metric says it could go higher
Autozone stock price is still in the rally zone
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
New highs are coming for Lowe’s stock despite mixed results
Closing prices for crude oil, gold and other commodities
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Consumer confidence slips in February as anxiety over potential recession surprisingly reappears
Beyond Meat's shares soar on better-than-expected Q4 revenue despite weak US sales
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
3 lithium stocks to ride a multi-year cycle
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Goldman upgraded Nvidia stock, one metric says it could go higher
Autozone stock price is still in the rally zone
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
New highs are coming for Lowe’s stock despite mixed results
Closing prices for crude oil, gold and other commodities
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Consumer confidence slips in February as anxiety over potential recession surprisingly reappears
Beyond Meat's shares soar on better-than-expected Q4 revenue despite weak US sales
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
3 lithium stocks to ride a multi-year cycle
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Goldman upgraded Nvidia stock, one metric says it could go higher
Autozone stock price is still in the rally zone
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
New highs are coming for Lowe’s stock despite mixed results
Closing prices for crude oil, gold and other commodities
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Consumer confidence slips in February as anxiety over potential recession surprisingly reappears
Beyond Meat's shares soar on better-than-expected Q4 revenue despite weak US sales

UiPath (PATH) Stock Price, News & Analysis

$23.67
-0.34 (-1.42%)
(As of 02/27/2024 ET)
Today's Range
$23.48
$24.33
50-Day Range
$21.60
$26.89
52-Week Range
$12.38
$27.87
Volume
10.39 million shs
Average Volume
9.51 million shs
Market Capitalization
$13.40 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.32

UiPath MarketRank™ Stock Analysis

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
5.7% Downside
$22.32 Price Target
Short Interest
Healthy
5.90% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.75mentions of UiPath in the last 14 days
Based on 19 Articles This Week
Insider Trading
Selling Shares
$17.58 M Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.03 out of 5 stars

Business Services Sector

201st out of 311 stocks

Prepackaged Software Industry

140th out of 201 stocks


PATH stock logo

About UiPath Stock (NYSE:PATH)

UiPath Inc. is a leading software company specializing in robotic process automation (RPA) technology. Headquartered in New York City, but founded in Bucharest, Romania, UiPath offers a comprehensive platform that automates repetitive tasks and enables businesses to operate more efficiently. The company was founded in 2005 by Romanian entrepreneurs Daniel Dines and Marius Tirca and has since grown to become a significant player in the RPA industry. UiPath has received numerous awards and accolades, including being named a leader in the Gartner Magic Quadrant for RPA Software in 2020.

UiPath's executive team is led by Chief Executive Officer and co-founder Daniel Dines, who has been with the company since its inception. Daniel is considered one of the pioneers of robotic process automation, helping start the industry. Mr. Dines contributes to his success in the industry by being relentless and constantly exposing himself to the industry's uncertainties. Other key management team members include Chief Financial Officer Ashim Gupta and Chief Marketing Officer Bobby Patrick. In 2021, UiPath announced that former Microsoft executive Tom Clancy would join as its new Senior Vice President of Learning.

UiPath has experienced significant growth in recent years, with revenue increasing exponentially since its inception. The company's net loss has been decreasing yearly. As of January 31, 2021, UiPath has cash, cash equivalents, and short-term investments capable of covering liabilities indicating that the company is working to keep control of its debt. UiPath's valuation has fluctuated since its IPO, with the company's market capitalization reaching a high of over $45 billion in May 2021 before falling to around $10 billion in Q4 of 2022. UiPath's price-to-sales ratio is higher than the industry average. Since its IPO in April 2021, UiPath's stock price has been volatile, with shares reaching a high of $90 in May 2021 before dropping to around $10 in November 2022. Since hitting its all-time low price, the stock has rebounded. Trading volume has also been relatively high, with an average of over 6 million shares traded per day.

The robotic process automation industry has experienced rapid growth in recent years as businesses seek to automate manual processes and increase efficiency. UiPath competes with several other robotic process automation providers, including Automation Anywhere, Blue Prism, and WorkFusion. In addition, the industry is subject to regulatory and political pressures, particularly around data privacy and security.

UiPath has identified several critical areas for growth, including expanding its product offerings to include artificial intelligence and machine learning capabilities and targeting new industries such as healthcare and financial services. The company has also been actively pursuing acquisitions, with recent purchases including Cloud Elements and ProcessGold.

As the robotic process automation industry continues to evolve, UiPath may face challenges from competitors who can offer similar or better technology at a lower cost. In addition, regulatory and political pressures may create uncertainty for the industry, which could impact UiPath's growth prospects.

PATH Stock Price History

PATH Stock News Headlines

Pegasystems flies on AI decision and workflow automation platform (PATH)
Pegasystems stock gapped up after reporting strong demand for its AI-powered CRM and BPM solutions; the company raised its full-year guidance
MarketBeat Week in Review – 2/5 - 2/9 (PATH)
The markets continue to rise as investors come to grips with higher interest rates, but next week's inflation data may cool down the bullish momentum
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT?
A little-known metal called vanadium is vital to American national security and energy independence. But right now, China and Russia dominate our supply. The U.S. Govt. is so serious about vanadium, it funded and recently completed an "Earth MRI" survey to seek out new sources of this energy metal - in Wyoming.
UiPath’s AI bots can trigger its tipping point in 2024
UiPath Inc. (NASDAQ: PATH) is the world’s largest provider of end-to-end robotic process automation (RPA) and business process automation (BPA) platforms.
Wells Fargo Keeps Their Hold Rating on UiPath (PATH)
Contrasting UiPath (NYSE:PATH) and Synopsys (NASDAQ:SNPS)
Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
3 Secret Stocks to Double Your Money by 2028
Here's My Top 4 Tech Stocks to Buy Right Now
7 Unstoppable Software Stocks Set to Soar in 2024
UiPath (NYSE:PATH) Coverage Initiated by Analysts at Scotiabank
Analyst Ratings For UiPath
UiPath: I Am Not Ready To Pay Premium Here
Where Will UiPath Stock Be in 1 Year?
See More Headlines
Receive PATH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for UiPath and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/30/2023
Today
2/27/2024
Next Earnings (Confirmed)
3/13/2024
Fiscal Year End
1/31/2025

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Fax
N/A
Employees
3,833
Year Founded
2005

Price Target and Rating

Average Stock Price Target
$22.32
High Stock Price Target
$27.50
Low Stock Price Target
$17.00
Potential Upside/Downside
-5.7%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
15 Analysts

Profitability

Net Income
$-328,350,000.00
Pretax Margin
-11.51%

Debt

Sales & Book Value

Annual Sales
$1.06 billion
Book Value
$3.45 per share

Miscellaneous

Free Float
390,424,000
Market Cap
$13.40 billion
Optionable
Optionable
Beta
0.97

Social Links

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report














PATH Stock Analysis - Frequently Asked Questions

Should I buy or sell UiPath stock right now?

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for UiPath in the last year. There are currently 9 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" PATH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PATH, but not buy additional shares or sell existing shares.
View PATH analyst ratings
or view top-rated stocks.

What is UiPath's stock price target for 2024?

15 Wall Street research analysts have issued 1 year target prices for UiPath's shares. Their PATH share price targets range from $17.00 to $27.50. On average, they anticipate the company's stock price to reach $22.32 in the next twelve months. This suggests that the stock has a possible downside of 5.7%.
View analysts price targets for PATH
or view top-rated stocks among Wall Street analysts.

How have PATH shares performed in 2024?

UiPath's stock was trading at $24.84 at the start of the year. Since then, PATH shares have decreased by 4.7% and is now trading at $23.67.
View the best growth stocks for 2024 here
.

Are investors shorting UiPath?

UiPath saw a drop in short interest in January. As of January 31st, there was short interest totaling 24,740,000 shares, a drop of 20.3% from the January 15th total of 31,060,000 shares. Based on an average daily volume of 9,970,000 shares, the short-interest ratio is currently 2.5 days. Currently, 5.9% of the company's shares are short sold.
View UiPath's Short Interest
.

When is UiPath's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 13th 2024.
View our PATH earnings forecast
.

How can I listen to UiPath's earnings call?

UiPath will be holding an earnings conference call on Wednesday, March 13th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

How were UiPath's earnings last quarter?

UiPath Inc. (NYSE:PATH) posted its quarterly earnings data on Thursday, November, 30th. The healthcare company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.10) by $0.05. The healthcare company earned $325.92 million during the quarter, compared to analyst estimates of $315.54 million. UiPath had a negative net margin of 12.51% and a negative trailing twelve-month return on equity of 5.98%.

What guidance has UiPath issued on next quarter's earnings?

UiPath updated its fourth quarter 2024 earnings guidance on Monday, December, 11th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $381.0 million-$386.0 million, compared to the consensus revenue estimate of $383.0 million.

When did UiPath IPO?

(PATH) raised $990 million in an initial public offering on Wednesday, April 21st 2021. The company issued 21,300,000 shares at $43.00-$50.00 per share. Morgan Stanley, JPMorgan, BofA Securities, Credit Suisse, Barclays and Wells Fargo Securities acted as the underwriters for the IPO and SMBC Nikko, BMO Capital Markets, Mizuho Securities USA, KeyBanc Capital Markets, TD Securities (USA), Truist SecuritiesCowen, Evercore Group, Macquarie Capital (USA), Nomura, RBC Capital Markets, Canaccord Genuity, D. A. Davidson & Co., Oppenheimer & Co. and Needham & Co. were co-managers.

Who are UiPath's major shareholders?

UiPath's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include ARK Investment Management LLC (7.68%), Vanguard Group Inc. (6.73%), Sumitomo Mitsui Trust Holdings Inc. (3.97%), Nikko Asset Management Americas Inc. (3.81%), Price T Rowe Associates Inc. MD (1.22%) and Norges Bank (1.18%). Insiders that own company stock include Ashim Gupta, Brad Brubaker, Daniel Dines, East Fund 2013 Sca Sic Digital, Hitesh Ramani, Kimberly Hammonds, Laela Sturdy, Philippe Botteri, Rich Wong, Ted Kummert and Thomas Neergaard Hansen.
View institutional ownership trends
.

How do I buy shares of UiPath?

Shares of PATH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does UiPath have any subsidiaries?
The following companies are subsidiares of UiPath: Cloud Elements, Cloud Elements Inc., CloudElements Technologies India Private Limited, MagnaView BV, ProcessGold A.G., ProcessGold B.V., ProcessGold International B.V., Re:infer, Shanghai Zhicheng Technology Co. Ltd., StepShot, The Conundrum IP LLC, UiPath AB, UiPath Australia Pty Ltd, UiPath Austria GmbH, UiPath Belgium BVBA, UiPath Brasil Consultoria Limitada, UiPath Business Solutions India Private Limited, UiPath Canada Operations Ltd., UiPath Denmark ApS, UiPath Finland Oy, UiPath France SAS, UiPath GMBH, UiPath Inc., UiPath Israel LTD, UiPath Italy SRL, UiPath Kabushiki Kaisha, UiPath Korea Ltd., UiPath Limited (Hong Kong), UiPath Ltd. (UK), UiPath Mexico S. DE R.L. DE C.V., UiPath Netherlands B.V., UiPath Netherlands Holding B.V., UiPath Norway AS, UiPath OOO, UiPath PTE LTD, UiPath Process Mining, UiPath Robotic Process Automation India Private Limited, UiPath SRL, UiPath South Africa (Pty) LTD, UiPath Switzerland GmbH, UiPath Ukraine LLC, and UiPath Ventures LLC.
Read More
This page (NYSE:PATH) was last updated on 2/28/2024 by MarketBeat.com Staff